ACT Genomics
Taiwan - TaipeiBiotechnology
Focus: ACT Genomics is a Taiwan-based biotechnology company specializing in cancer genomic profiling and sequencing analysis. The company operates as a publicly listed entity focused on oncology applications.
Profile data last refreshed 19h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
3
Should You Work at ACT Genomics?
AI assessmentBest suited for genomics specialists seeking niche expertise in a stable Asian biotech; limited career runway for those seeking rapid advancement or robust pipeline exposure.
Why Work Here
- Specialized niche in cancer genomics profiling with established public market credibility since 2014
- Exposure to precision oncology and diagnostic genomics, a high-growth therapeutic area
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
non intervention
Sequence AnalysisClinical Trials (1)
NCT03719222Analysis of Tumor Mutations and Tumor Microenvironment Using Archival Paraffin-embedded Tumor Specimens
N/AHelp build intelligence for ACT Genomics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.